Nuclear oncoprotein prothymosin α is a partner of Keap1: Implications for expression of oxidative stress-protecting genes

Molecular and Cellular Biology

Volumn 25, Issue 3, 2005, Pages 1089-1099

  Karapetian, Ruben N ^a   Evstafieva, Alexandra G ^a   Abaeva, Irina S ^a   Chichkova, Nina V ^a   Filonov, Grigoriy S ^a   Rubtsov, Yuri P ^a   Sukhacheva, Elena A ^b   Melnikov, Sergey V ^a   Schneider, Ulrich ^c   Wanker, Erich E ^d   Vartapetian, Andrey B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN KEAP1; PROTHYMOSIN ALPHA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR EXPORT SIGNAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RNA INTERFERENCE; TWO HYBRID SYSTEM;

ACTIVE TRANSPORT, CELL NUCLEUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEINS; RNA, SMALL INTERFERING; THYMOSIN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA;

EID: 19944430116     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.3.1089-1099.2005     Document Type: Article

References (45)

1. Adams, J., R. Kelso, and L. Cooley. 2000. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol. 10:17-24.
2. Alam, J., D. Stewart, C. Touchard, S. Boinapally, A. M. Choi, and J. L. Cook. 1999. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274:26071-26078.
3. Bloom, D. A., and A. K. Jaiswal. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278:44675-44682.
4. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
5. Chichkova, N. V., A. G. Evstafieva, I. G. Lyakhov, A. S. Tsvetkov, T. A. Smirnova, R. N. Karapetian, E. M. Karger, and A. B. Vartapetian. 2000. Divalent metal cation binding properties of human prothymosin alpha. Eur. J. Biochem. 267:4745-4752.
6. Clinton, M., L. Graeve, H. el-Dorry, E. Rodriguez-Boulan, and B. L. Horecker. 1991. Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ. Proc. Natl. Acad. Sci. USA 88:6608-6612.
7. Cullinan, S. B., D. Zhang, M. Hannink, E. Arvisais, R. J. Kaufman, and J. A. Diehl. 2003. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23:7198-7209.
8. Dhakshinamoorthy, S., and A. K. Jaiswal. 2001. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20:3906-3917.
9. Dinkova-Kostova, A. T., W. D. Holtzclaw, R. N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99:11908-11913.
10. Dominguez, F., C. Magdalena, E. Cancio, E. Roson, J. Paredes, L. Loidi, J. Zalvide, M. Fraga, J. Forteza, B. J. Regueiro, and J. L. Puente. 1993. Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer. Eur. J. Cancer 29A:893-897.
11. Eschenfeldt, W. H., and S. L. Berger. 1986. The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc. Natl. Acad. Sci. USA 83:9403-9407.
12. Evstafieva, A. G., G. A. Belov, M. Kalkum, N. V. Chichkova, A. A. Bogdanov, V. I. Agol, and A. B. Vartapetian. 2000. Prothymosin alpha fragmentation in apoptosis. FEBS Lett. 467:150-154.
13. Evstafieva, A. G., G. A. Belov, Y. P. Rubtsov, M. Kalkum, B. Joseph, N. V. Chichkova, E. A. Sukhacheva, A. A. Bogdanov, R. F. Pettersson, V. I. Agol, and A. B. Vartapetian. 2003. Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha. Exp. Cell Res. 284:211-223.
14. Gomez-Marquez, J., F. Segade, M. Dosil, J. G. Pichel, X. R. Bustelo, and M. Freire. 1989. The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. J. Biol. Chem. 264:8451-8454.
15. Hayes, J. D., and M. McMahon. 2001. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174:103-113.
16. Huang, H. C., T. Nguyen, and C. B. Pickett. 2002. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277:42769-42774.
17. Ishii, T., K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275:16023-16029.
18. Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313-322.
19. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J. D. Engel, and M. Yamamoto. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76-86.
20. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, T. O'Connor, and M. Yamamoto. 2003. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8:379-391.
21. Jiang, X., H. E. Kim, H. Shu, Y. Zhao, H. Zhang, J. Kofron, J. Donnelly, D. Burns, S. C. Ng, S. Rosenberg, and X. Wang. 2003. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299:223-226.
22. Kang, M. I., A. Kobayashi, N. Wakabayashi, S. G. Kim, and M. Yamamoto. 2004. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA 101:2046-2051.
23. Karetsou, Z., A. Kretsovali, C. Murphy, O. Tsolas, and T. Papamarcaki. 2002. Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription. EMBO Rep. 3:361-366.
24. Levonen, A. L., A. Landar, A. Ramachandran, E. K. Ceaser, D. A. Dickinson, G. Zanoni, J. D. Morrow, and V. M. Darley-Usmar. 2004. Cellular mechanisms of redox cell signaling: the role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem. J. 378:373-382.
25. Manrow, R. E., A. R. Sburlati, J. A. Hanover, and S. L. Berger. 1991. Nuclear targeting of prothymosin alpha. J. Biol. Chem. 266:3916-3924.
26. Martini, P. G., R. Delage-Mourroux, D. M. Kraichely, and B. S. Katzenellenbogen. 2000. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol. Cell. Biol. 20:6224-6232.
27. McMahon, M., K. Itoh, M. Yamamoto, S. A. Chanas, C. J. Henderson, L. I. McLellan, C. R. Wolf, C. Cavin, and J. D. Hayes. 2001. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61:3299-3307.
28. McMahon, M., K. Itoh, M. Yamamoto, and J. D. Hayes. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278:21592-21600.
29. Motohashi, H., F. Katsuoka, J. D. Engel, and M. Yamamoto. 2004. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. USA 101:6379-6384.
30. Orre, R. S., M. A. Cotter II, C. Subramanian, and E. S. Robertson. 2001. Prothymosin alpha functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro. J. Biol. Chem. 276:1794-1799.
31. Ramos-Gomez, M., M. K. Kwak, P. M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T. W. Kensler. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98:3410-3415.
32. Rodriguez, P., J. E. Vinuela, L. Alvarez-Fernandez, M. Buceta, A. Vidal, F. Dominguez, and J. Gomez-Marquez. 1998. Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells. Biochem. J. 331:753-761.
33. Rodriguez, P., J. E. Vinuela, L. Alvarez-Fernandez, and J. Gomez-Marquez. 1999. Prothymosin alpha antisense oligonucleotides induce apoptosis in HL-60 cells. Cell Death Differ. 6:3-5.
34. Rubtsov, Y. P., A. S. Zolotukhin, I. A. Vorobjev, N. V. Chichkova, N. A. Pavlov, E. M. Karger, A. G. Evstafieva, B. K. Felber, and A. B. Vartapetian. 1997. Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signal. FEBS Lett. 413:135-141.
35. Rushmore, T. H., M. R. Morton, and C. B. Pickett. 1991. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:11632-11639.
36. Sburlati, A. R., R. E. Manrow, and S. L. Berger. 1991. Prothymosin alpha antisense oligomers inhibit myeloma cell division. Proc. Natl. Acad. Sci. USA 88:253-257.
37. Sukhacheva, E. A., A. G. Evstafieva, T. V. Fateeva, V. R. Shakulov, N. A. Efimova, R. N. Karapetian, Y. P. Rubtsov, and A. B. Vartapetian. 2002. Sensing prothymosin alpha origin, mutations and conformation with monoclonal antibodies. J. Immunol. Methods 266:185-196.
38. Tsitsiloni, O. E., J. Stiakakis, A. Koutselinis, J. Gogas, C. Markopoulos, P. Yialouris, S. Bekris, D. Panoussopoulos, V. Kiortsis, W. Voelter, and A. A. Haritos. 1993. Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc. Natl. Acad. Sci. USA 90:9504-9507.
39. Vareli, K., M. Frangou-Lazaridis, I. van der Kraan, O. Tsolas, and R. van Driel. 2000. Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication. Exp. Cell Res. 257:152-161.
40. Wakabayashi, N., K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, S. Takahashi, S. Imakado, T. Kotsuji, F. Otsuka, D. R. Roop, T. Harada, J. D. Engel, and M. Yamamoto. 2003. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35:238-245.
41. Wakabayashi, N., A. T. Dinkova-Kostova, W. D. Holtzclaw, M. I. Kang, A. Kobayashi, M. Yamamoto, T. W. Kensler, and P. Talalay. 2004. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. USA 101:2040-2045.
42. Wanker, E. E., C. Rovira, E. Scherzinger, R. Hasenbank, S. Walter, D. Tait, J. Colicelli, and H. Lehrach. 1997. HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6:487-495.
43. Wu, C. L., A. L. Shiau, and C. S. Lin. 1997. Prothymosin alpha promotes cell proliferation in NIH3T3 cells. Life Sci. 61:2091-2101.
44. Xue, F., and L. Cooley. 1993. kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 72:681-693.
45. Zhang, D. D., and M. Hannink. 2003. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23:8137-8151.